Key result
Chinese herbal medicine may offer a novel approach to simultaneously target reproductive and metabolic defects in polycystic ovary syndrome, warranting further investigation.
Why the study?
Does Chinese herbal medicine improve reproductive and metabolic complications in women with polycystic ovary syndrome?
Does Chinese herbal medicine improve reproductive and metabolic complications in women with polycystic ovary syndrome?
Chinese herbal medicine represents a potential therapeutic avenue for addressing both the reproductive and metabolic components of PCOS, though further clinical investigation is needed.
May address dual PCOS complications; leaves open confirmation in randomized trials before practice change.
Polycystic ovary syndrome (PCOS) is a complex heterogeneous disorder characterized by androgen excess and ovulatory dysfunction; it is now known to be closely linked to metabolic syndrome. Recent research suggests that insulin resistance plays an important role in the pathogenesis of PCOS which may lead to the excessive production of androgens by ovarian theca cells. Currently there is no single drug that can treat both the reproductive and metabolic complications of the disorder. Existing pharmaceutical agents such as hormonal therapies have been associated with side effects and are not appropriate for PCOS women with infertility. Additionally, insulin sensitizing agents useful for treating the metabolic abnormalities in PCOS have limited efficacy for treating reproductive aspects of the disorder. Chinese herbal medicines have a long history of treating gynaecological problems and infertility and therefore may be a novel approach to the treatment of PCOS. Current research demonstrates that the compounds isolated from herbs have shown beneficial effects for PCOS and when combined in an herbal formula can target both reproductive and metabolic defects simultaneously. Therefore, further investigation into Chinese herbal medicine in the treatment of PCOS is warranted.
No takes yet. Share an insight, caveat, or question.
Ong et al. (2017) conducted a review in Polycystic ovary syndrome (PCOS). Chinese herbal medicine was evaluated. Chinese herbal medicine may offer a novel approach to simultaneously target reproductive and metabolic defects in polycystic ovary syndrome, warranting further investigation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: